S Liu1, J Rouleau1, J A León1, R Sauve2, K S Joseph3,4,5, J G Ray6. 1. Maternal, Child & Youth Health Unit, Surveillance and Epidemiology Division, Centre for Chronic Disease Prevention, Public Health Agency of Canada, Ottawa, Ontario, Canada. 2. Departments of Pediatrics and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada. 3. Department of Obstetrics & Gynaecology, University of British Columbia, Vancouver, British Columbia, Canada. 4. Children's and Women's Hospital of British Columbia, Vancouver, British Columbia, Canada. 5. School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada. 6. Departments of Medicine, Health Policy Management and Evaluation, and Obstetrics and Gynecology, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
Abstract
OBJECTIVE: To examine the impact of pre-pregnancy diabetes mellitus (DM) on the population birth prevalence of congenital anomalies in Canada. METHODS: We carried out a population-based study of all women who delivered in Canadian hospitals (except those in the province of Quebec) between April 2002 and March 2013 and their live-born infants with a birth weight of 500 grams or more and/or a gestational age of 22 weeks or more. Pre-pregnancy type 1 or type 2 DM was identified using ICD-10 diagnostic codes. The association between DM and all congenital anomalies as well as specific congenital anomaly categories was estimated using adjusted odds ratios; the impact was calculated as a population attributable risk percent (PAR%). RESULTS: There were 118,892 infants with a congenital anomaly among 2,839,680 live births (41.9 per 1000). While the prevalence of any congenital anomaly declined from 50.7 per 1000 live births in 2002/03 to 41.5 per 1000 in 2012/13, the corresponding PAR% for a congenital anomaly related to pre-pregnancy DM rose from 0.6% (95% confidence interval [CI]: 0.4-0.8) to 1.2% (95% CI: 0.9-1.4). Specifically, the PAR% for congenital cardiovascular defects increased from 2.3% (95% CI: 1.7-2.9) to 4.2% (95% CI: 3.5-4.9) and for gastrointestinal defects from 0.8% (95% CI: 0.2-1.9) to 1.4% (95% CI: 0.7-2.6) over the study period. CONCLUSION: Although there has been a relative decline in the prevalence of congenital anomalies in Canada, the proportion of congenital anomalies due to maternal pre-pregnancy DM has increased. Enhancement of preconception care initiatives for women with DM is recommended.
OBJECTIVE: To examine the impact of pre-pregnancy diabetes mellitus (DM) on the population birth prevalence of congenital anomalies in Canada. METHODS: We carried out a population-based study of all women who delivered in Canadian hospitals (except those in the province of Quebec) between April 2002 and March 2013 and their live-born infants with a birth weight of 500 grams or more and/or a gestational age of 22 weeks or more. Pre-pregnancy type 1 or type 2 DM was identified using ICD-10 diagnostic codes. The association between DM and all congenital anomalies as well as specific congenital anomaly categories was estimated using adjusted odds ratios; the impact was calculated as a population attributable risk percent (PAR%). RESULTS: There were 118,892 infants with a congenital anomaly among 2,839,680 live births (41.9 per 1000). While the prevalence of any congenital anomaly declined from 50.7 per 1000 live births in 2002/03 to 41.5 per 1000 in 2012/13, the corresponding PAR% for a congenital anomaly related to pre-pregnancy DM rose from 0.6% (95% confidence interval [CI]: 0.4-0.8) to 1.2% (95% CI: 0.9-1.4). Specifically, the PAR% for congenital cardiovascular defects increased from 2.3% (95% CI: 1.7-2.9) to 4.2% (95% CI: 3.5-4.9) and for gastrointestinal defects from 0.8% (95% CI: 0.2-1.9) to 1.4% (95% CI: 0.7-2.6) over the study period. CONCLUSION: Although there has been a relative decline in the prevalence of congenital anomalies in Canada, the proportion of congenital anomalies due to maternal pre-pregnancy DM has increased. Enhancement of preconception care initiatives for women with DM is recommended.
Authors: Shiliang Liu; K S Joseph; Jennifer A Hutcheon; Sharon Bartholomew; Juan Andrés León; Mark Walker; Michael S Kramer; Robert M Liston Journal: Am J Obstet Gynecol Date: 2013-05-20 Impact factor: 8.661
Authors: K S Joseph; Brooke Kinniburgh; Jennifer A Hutcheon; Azar Mehrabadi; Melanie Basso; Cheryl Davies; Lily Lee Journal: CMAJ Date: 2013-04-08 Impact factor: 8.262
Authors: Shiliang Liu; K S Joseph; Michael S Kramer; Alexander C Allen; Reg Sauve; I D Rusen; Shi Wu Wen Journal: JAMA Date: 2002-03-27 Impact factor: 56.272
Authors: James L Mills; James Troendle; Mary R Conley; Tonia Carter; Charlotte M Druschel Journal: Am J Clin Nutr Date: 2010-04-07 Impact factor: 7.045
Authors: Shiliang Liu; K S Joseph; Sarka Lisonkova; Jocelyn Rouleau; Michiel Van den Hof; Reg Sauve; Michael S Kramer Journal: Circulation Date: 2013-06-28 Impact factor: 29.690
Authors: Philippe De Wals; Fassiatou Tairou; Margot I Van Allen; Soo-Hong Uh; R Brian Lowry; Barbara Sibbald; Jane A Evans; Michiel C Van den Hof; Pamela Zimmer; Marian Crowley; Bridget Fernandez; Nora S Lee; Theophile Niyonsenga Journal: N Engl J Med Date: 2007-07-12 Impact factor: 91.245
Authors: Yuxiao Wu; Buyun Liu; Yangbo Sun; Yang Du; Mark K Santillan; Donna A Santillan; Linda G Snetselaar; Wei Bao Journal: Diabetes Care Date: 2020-10-21 Impact factor: 19.112
Authors: Laura I Parikh; Katherine L Grantz; Sara N Iqbal; Chun-Chih Huang; Helain J Landy; Melissa H Fries; Uma M Reddy Journal: Am J Obstet Gynecol Date: 2017-05-31 Impact factor: 8.661
Authors: Romy van de Putte; Iris A L M van Rooij; Cynthia P Haanappel; Carlo L M Marcelis; Han G Brunner; Marie-Claude Addor; Clara Cavero-Carbonell; Carlos M Dias; Elizabeth S Draper; Larraitz Etxebarriarteun; Miriam Gatt; Babak Khoshnood; Agnieszka Kinsner-Ovaskainen; Kari Klungsoyr; Jenny J Kurinczuk; Anna Latos-Bielenska; Karen Luyt; Mary T O'Mahony; Nicola Miller; Carmel Mullaney; Vera Nelen; Amanda J Neville; Isabelle Perthus; Anna Pierini; Hanitra Randrianaivo; Judith Rankin; Anke Rissmann; Florence Rouget; Bruno Schaub; David Tucker; Diana Wellesley; Awi Wiesel; Natalya Zymak-Zakutnia; Maria Loane; Ingeborg Barisic; Hermien E K de Walle; Jorieke E H Bergman; Nel Roeleveld Journal: Birth Defects Res Date: 2020-04-22 Impact factor: 2.344
Authors: Alexander J F Davidson; Alison L Park; Howard Berger; Kazuyoshi Aoyama; Ziv Harel; Eyal Cohen; Jocelynn L Cook; Joel G Ray Journal: JAMA Netw Open Date: 2020-12-01